JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Resources
Ruth Olbido

Ruth Olbido

Antibodies in Clinic / Clinical Trials

Bentracimab: The First-in-Class Reversal Agent for Ticagrelor

Ruth Olbido - February 25, 2026

Bentracimab: The First-in-Class Reversal Agent for Ticagrelor
...

Read more
Antibodies in Clinic / Clinical Trials

A Researcher’s Guide to Narsoplimab: Structure, Mechanism of Action, and Clinical Efficacy in TA-TMA

Ruth Olbido - January 07, 2026

Narsoplimab: Structure, Mechanism of Action, and Clinical Efficacy in TA-TMA
...

Read more
Antibodies in Clinic / Clinical Trials

A Researcher’s Guide to Depemokimab: Structure, Mechanism of Action, and Clinical Efficacy in Eosinophilic Diseases

Ruth Olbido - December 22, 2025

Depemokimab: Structure, Mechanism of Action, and Clinical Efficacy in Eosinophilic Diseases
...

Read more
Antibodies in Clinic / Clinical Trials

A Researcher’s Guide to Picankibart: Structure, Mechanism of Action, and Clinical Efficacy in Psoriasis

Ruth Olbido - December 03, 2025

Picankibart: Structure, Mechanism of Action, and Clinical Efficacy in Psoriasis
...

Read more
Antibodies in Clinic / Clinical Trials

A Researcher’s Guide to Sibeprenlimab: Structure, Mechanism of Action, and Clinical Efficacy in IgAN

Ruth Olbido - November 30, 2025

Sibeprenlimab: Structure, Mechanism of Action, and Clinical Efficacy in IgAN
...

Read more
Antibodies in Clinic / Clinical Trials

A Researcher’s Guide to Trastuzumab Botidotin: Structure, Mechanism of Action, and Clinical Efficacy

Ruth Olbido - October 28, 2025

Trastuzumab Botidotin: Structure, Mechanism of Action, and Clinical Efficacy
...

Read more

↑

Back to Top